Neurosteroids have similarly been closely tied to the anxiolytic effects of TSPO, with ligands etifoxine being approved for treating anxiety (Nguyen et al., 2006) and brexanolone, the aqueous formulation of allopregnanolone, for treatment of postpartum depression (Scarff, 2019). This evidence concerns the gene TSPO and Anxiety.